All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Fundamental physical and chemical concepts behind "drug-likeness" and "natural product-likeness"

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22310%2F19%3A43919350" target="_blank" >RIV/60461373:22310/19:43919350 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.degruyter.com/view/j/psr.2019.4.issue-12/psr-2018-0101/psr-2018-0101.xml" target="_blank" >https://www.degruyter.com/view/j/psr.2019.4.issue-12/psr-2018-0101/psr-2018-0101.xml</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1515/psr-2018-0101" target="_blank" >10.1515/psr-2018-0101</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Fundamental physical and chemical concepts behind "drug-likeness" and "natural product-likeness"

  • Original language description

    The discovery of a drug is known to be quite cumbersome, both in terms of the microscopic fundamental research behind it and the industrial scale manufacturing process. A major concern in drug discovery is the acceleration of the process and cost reduction. The fact that clinical trials cannot be accelerated, therefore, emphasizes the need to accelerate the strategies for identifying lead compounds at an early stage. We, herein, focus on the definition of what would be regarded as a &quot;drug-like&quot; molecule and a &quot;lead-like&quot; one. In particular, &quot;drug-likeness&quot; is referred to as resemblance to existing drugs, whereas &quot;lead-likeness&quot; is characterized by the similarity with structural and physicochemical properties of a &quot;lead&quot;compound, i.e. a reference compound or a starting point for further drug development. It is now well known that a huge proportion of the drug discovery is inspired or derived from natural products (NPs), which have larger complexity as well as size when compared with synthetic compounds. Therefore, similar definitions of &quot;drug-likeness&quot; and &quot;leadlikeness&quot; cannot be applied for the NP-likeness. Rather, there is the dire need to define and explain NP-likeness in regard to chemical structure. An attempt has been made here to give an overview of the general concepts associated with NP discovery, and to provide the foundational basis for defining a molecule as a &quot;drug&quot;, a &quot;lead&quot; or a &quot;natural compound.&quot;

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30107 - Medicinal chemistry

Result continuities

  • Project

    <a href="/en/project/EF16_027%2F0008351" target="_blank" >EF16_027/0008351: ChemJets UCT Prague</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Physical Sciences Reviews

  • ISSN

    2365-6581

  • e-ISSN

    2365-659X

  • Volume of the periodical

    4

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    18

  • Pages from-to

  • UT code for WoS article

    000498892300004

  • EID of the result in the Scopus database